Confused
by stem cells?
Read
this easy to understand overview
A brighter future
Stem Cell Therapy has moved beyond ‘promising’. Substantial
patient improvement from stem cell therapy has been documented,
with minimal risk.
Stem
cells will completely alter the way we practice medicine. They
are the cells from which we are made, and when we re-introduce
them to a diseased body, we have seen positive change occur -
without the need for medication - that is often powerful, but
toxic. With Regenecell Stem Cell Treatment, no immune system ablation
(destruction) will occur, and there is no use made of chemotherapy,
steroids or antibiotics. Documentation to date establishes the
procedure as safe. (1)
Quality Treatment
Regenecell provides stem cell treatment, using umbilical cord
stem cells under strictly prescribed conditions. This covers the
entire process – from manufacture to transport and final
administration to the patient. With Regenecell you are guaranteed
the highest possible level of quality treatment by medical practitioners
with experience and credentials that would be impressive in mainstream
medicine anywhere in the world.
Stem Cells
The cells we use come from the blood left behind in the placenta
after a baby is born. This blood has been formed by the cells
contained in the embryo, and has not been in contact with the
mother’s blood. The cells contained in this blood are left
over from this process of creation and would normally be discarded.
This means that we have the building blocks of human beings available
to repair and regenerate diseased human tissue via a natural state.
Cell Quality
Each vial of our stem cells is accompanied by a Certificate of
Analysis, approved by a qualified microbiologist. You will be
issued a copy of this certificate, which will include measures
of viability and purity. This includes tests done on the mother
as well as the cord blood before and after culture, covering amongst
others: HIV, Hepatitis B, and bacteria.
To see an example of a certificate, click
here
Safe Process
Umbilical cord stem cells allow us to treat patients without the
harmful cytotoxic agents which would result in immune suppression.
Our product is pure and does not contain any cells or particles
that could cause an allergic reaction. Stem cells are ‘immature’,
lacking the ability to be recognized by the immune system, making
the risk of an allergic reaction very unlikely.
The product is as safe as any blood product from a blood bank
and is tested twice - before and after processing - to make sure
it is free from disease and contamination before being cryopreserved.
With Regenecell, the process is an accountable one with the same
stringent protocols applying to stem cell treatment as to any
specialised medical procedure adhering to global best practice
standards.
How stem cells work
These cells are capable of performing three important functions
with unique abilities:
- Plasticity: Potential to change into other cell types like nerve
cells (2)
- Homing: To travel to the site of tissue damage (3,4)
- Engraftment: To unite with other tissues (5)
This means that, if we inject our specific stem cell into a patient
who has a nerve disorder, that cell should migrate to the site
of injury attracted by specific chemicals released by the damaged
tissue. The cell, by homing to the damaged area will fuse with
the damaged tissue by the process of engraftment and become the
same tissue by displaying the property of plasticity. In this
instance, the stem cell should, for example, become a nerve cell.
The rest of the injected cells, which have not migrated or engrafted,
will travel to the bone marrow where they will be stored with
the body’s blood cells until needed. They can still respond,
from the bone marrow, to signals from damaged tissue elsewhere
in the body and migrate to that site. This is why responses are
sometimes not noted until a few months after treatment.
Immediately after the cells are injected, the body secretes numerous
chemicals called cytokines. They can cause the remarkable effects
sometimes seen immediately after treatment, but are usually transitory,
although these effects have persisted on occasion.
Find Out More
Should you wish to investigate stem cell treatment further, these
are reputable sites for information:
http://www.explorestemcells.co.uk/
Expert advice on stem cells (for beginners)
http://stemcells.nih.gov/info/basics
This document covers basic information about stem cells and is
presented by the National Institute of Health.
http://www.isscr.org
The International Society for Stem Cell Research is an independent,
nonprofit organization formed in 2002 to foster the exchange of
information on stem cell research.
http://www.isscr.org/science/faq.htm
The International Society for Stem Cell Research FAQ section.
An excellent source for the answers to common questions
http://www.stemcellnetwork.ca
The Stem Cell Network is a bold venture for Canada that brings
together more than 70 leading scientists, clinicians, engineers,
and ethicists, with the mandate to investigate the immense therapeutic
potential of stem cells for the treatment of diseases currently
incurable by conventional approaches.
http://learn.genetics.utah.edu
The University of Utah Genetic Science Learning Centre. Look for
the stem cell link.
http://www.stemcellresearchfoundation.org
The Stem Cell Research Foundation (SCRF) supports innovative basic
and clinical research in the emerging and critical area of stem
cell therapy.
References
1 Riordan NH, Chan K, Marleau AM, Ichim TE.
Cord blood in regenerative medicine: Do we need immune suppression?
J Transl Med. 2007 Jan 30;5(1):8.
2. Aubin, J. E., & Triffitt, J. (2002). Messenchymal
stem cells and the osteoblast lineage. In J. P. Bilezikian, L.
G. Raisz & G. A. Rodan (Eds.), Principals of Bone Biology
(2 ed., pp. 59-81).
3. Mueller FJ, McKercher SR, Imitola J, Loring
JF, Yip S, Khoury SJ, Snyder EY. At the interface of the immune
system and the nervous system: how neuroinflammation modulates
the fate of neural progenitors in vivo. Ernst Schering Res Found
Workshop. 2005;(53):83-114.
4. A joint effort led by stem cell biologist
Evan Y. Snyder, M.D., Ph.D., of The Burnham Institute, and Samia
J. Khoury, M.D., of Harvard Medical School and Brigham and Women’s
Hospital, report data suggesting that stem cells use inflammatory
signals to “know” where they must home. http://www.burnham.org/default.asp?contentID=83.
Inflammation Directs Stem Cells to Injured Tissue Dec 16, 2004.
5. Kofidis, T., de Bruin, J. L., Yamane, T.,
Balsam, L. B., Lebl, D. R., Swijnenburg, R.-J., Tanaka, M., Weissman,
I. L., and Robbins, R. C. (2004). Insulin-Like Growth Factor Promotes
Engraftment, Differentiation, and Functional Improvement after
Transfer of Embryonic Stem Cells for Myocardial Restoration .
Stem Cells 22 , 1239-1245
.
